News
Public · Published
Key facts: Oracle Plans $20B Raise; Stephens Upgrades; Shares Rise 11%
Oracle plans to raise about $20 billion for cloud and AI investment and other needs, including selling 86.2 million shares at $116 and issuing $10 billion in bonds. Stephens upgraded Oracle to Buy from Hold and raised its price target to $213 from $185; Oracle shares rose about 11% on Oct. 28.
Published:
Updated:
What happened
Oracle plans to raise about $20 billion for cloud and AI investment and other needs, including selling 86.2 million shares at $116 and issuing $10 billion in bonds. Stephens upgraded Oracle to Buy from Hold and raised its price target to $213 from $185; Oracle shares rose about 11% on Oct. 28.
Confirmed
Global impact / market context
The share sale brings in cash but adds shares, which can reduce existing investors’ ownership percentage. Bonds bring in borrowed money and require interest payments; the stated 7%–8.65% yields indicate a financing cost. Together, these funding choices support Oracle’s planned AI expansion while affecting future costs and share ownership.
Analyst inference
The article links Oracle’s 11% share rise on Oct. 28 to its statement that fiscal-year capital spending should peak this year and that it would raise up to $20 billion for AI expansion through fiscal 2030. Stephens cited reduced uncertainty over future financing needs in its upgrade.
Confirmed
What to watch
- Check whether Oracle completes the planned share sale and bond issuance, and whether the amount raised matches its stated funding plan for cloud, AI, and other needs. Analyst inference
- Watch for updates on AI expansion spending through fiscal 2030 and whether Oracle’s statement that capital spending should peak this year remains its plan. Analyst inference
- Track future financing disclosures: Stephens’s upgrade cited less uncertainty about Oracle’s financing needs, so further funding could increase borrowing costs or dilute shareholders, meaning each share represents a smaller ownership stake. Analyst inference
Evidence
- Original source link unavailable